Treatment Outcomes for Childhood Acute Lymphoblastic Leukemia in Resource-Limited Settings: A Hybrid Risk-Stratified Treatment Protocol Without Minimal Residual Disease Measurement

被引：0
|
作者：
Alsakka, Suzan [1 ]
Jneidi, Safaa [1 ]
Ghanem, Khaled [1 ]
机构：
[1] BASMA Pediat Oncol Unit, Damascus, Syria
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
ALL; children; low income; MRD;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ALL-572
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 50 条
  • [1] Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome
    Lashkari, Harsha Prasada
    Faheem, Moideen
    Sridevi Hanaganahalli, Basaviah
    Bhat, Kamalakshi G.
    Joshi, Jayatheerth
    Kamath, Nutan
    Ahlawat, Shivali
    Prashantha, B.
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (10) : 1143 - 1151
  • [2] Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India
    Mungle, Tushar
    Das, Nandana
    Pal, Saikat
    Gogoi, Manash Pratim
    Das, Parag
    Ghara, Niharendu
    Ghosh, Debjani
    Arora, Ramandeep Singh
    Bhakta, Nickhill
    Saha, Vaskar
    Krishnan, Shekhar
    CANCER MEDICINE, 2023, 12 (03): : 3499 - 3508
  • [3] Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon
    Muwakkit, Samar
    Al-Aridi, Carol
    Samra, Ahmad
    Saab, Raya
    Mahfouz, Rami A.
    Farra, Chantal
    Jeha, Sima
    Abboud, Miguel R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (07) : 678 - 683
  • [4] Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in China
    Shen, Shuhong
    Cai, Jiaoyang
    Chen, Jing
    Xue, Huiliang
    Pan, Ci
    Gao, Yijin
    Tang, Yanjing
    Wang, Jianmin
    Li, Benshang
    Wang, Xiang
    Chen, Jing
    Gu, Longjun
    Tang, Jingyan
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (04) : 679 - 688
  • [5] THE MINIMAL RESIDUAL DISEASE DIRECTED TREATMENT INTERVENTION STRATEGY OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Tang, Y.
    Li, B.
    Tang, J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 69 - 69
  • [6] Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemia
    Latham, Sue
    Hughes, Elizabeth
    Budged, Bradley
    Mechinaud, Francoise
    Crock, Catherine
    Ekert, Henry
    Campbell, Peter
    Morley, Alexander
    PLOS ONE, 2017, 12 (10):
  • [7] Treatment outcomes for childhood acute lymphoblastic leukemia in low-middle income country before minimal residual disease risk stratification
    Makkeyah, Sara
    Manzour, Ayat
    Tantawy, Azza
    Mohamed, Ashraf
    Ebeid, Fatma
    El-Sherif, Nayera
    Abd El-Ghany, Shereen
    Shawiesh, Mahmoud
    Ali, Heba
    Sayed, Safa
    Ragab, Iman
    CANCER EPIDEMIOLOGY, 2021, 75
  • [8] MINIMAL RESIDUAL DISEASE AND RISK-GROUPING IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Borowitz, Michael
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) : 390 - 390
  • [9] Long-Term Results of the Risk-Stratified Treatment of Childhood Acute Lymphoblastic Leukemia in China: A Retrospective Study of the SCMC-ALL-2005 Protocol
    Cai, J.
    Shen, S.
    Chen, J.
    Xue, H.
    Pan, C.
    Gao, Y.
    Tang, Y.
    Wang, J.
    Li, B.
    Wang, X.
    Chen, J.
    Gu, L.
    Tang, J.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S105 - S105
  • [10] SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource-limited settings
    Bansal, Deepak
    Davidson, Alan
    Supriyadi, Eddy
    Njuguna, Festus
    Ribeiro, Raul C.
    Kaspers, Gertjan J. L.
    PEDIATRIC BLOOD & CANCER, 2024, 70 (11)
12345